We embody the meaning of our namesake, freenome. For those who do not know:
freenome (pronounced free•nohm) is the dynamic collection of genetic material floating in your blood (cell-free) derived from the trillions of cells in your body. It is your living cell-free genome changing over time. Your freenome is the genomic thermometer of who you are as you grow, live and age.
March 25, 2015 - Wednesday
Riley Ennis's work on the use of nanoparticles for improved drug delivery has been released in the peer-reviewed Journal of Biotechnology. Magnetic nanoparticle hyperthermia induced cytosine deaminase expression in mircroencapsulated E. coli for enzyme-prodrug therapy was co-authored by Barjor Gimi and Krishnamurthy V. Nemani as a multi-department collaboration at Dartmouth College.
His paper can be found here.
March 10, 2016 - Thursday
It was an exciting week at Molecular Tri-Con 2016 in San Francisco. There was an incredible showing of scientists at the cutting edge of liquid biopsy diagnostics. Freenome's computational biologist, Adam Drake, gave a riveting presentation on Freenome’s research progress in prostate and lung cancer to a packed room. After describing Freenome’s wet lab methods for sequencing cell free plasma DNA he guided the audience through Freenome’s unique algorithmically driven perspective on cancer diagnostics. The results impressed the cell free sequencing experts in the room. He fielded a stimulating discussion on the "nitty gritty" of statistical learning techniques and the stumbling blocks Freenome has run into and anticipates in bringing a sequencing test to the clinic. Great work Adam. Freenome can’t wait to return next year to share another year of progress in the rapidly developing field.
Freenome is excited to welcome Adam Drake to the research team! Adam conducted computational biology research alongside CEO, Gabe Otte at University of Pennsylvania and has contributed to a number of high-impact academic papers. With expertise in biochemistry, evolutionary biology, and computational biology, he has developed expertise in machine learning and statistical analysis of genome-wide data. He continues to innovate in the growing field of genomic analysis.
November 5, 2015 - Thursday
The Web Summit is one of the largest technology conferences with 42,000 attendees from more than 134 countries. On the first day of the conference our co-founder, Riley Ennis, delivered an evening keynote on the Freenome story as well as his experiences through working with pharmaceutical companies to leverage their expertise to accelerate internal innovation. On the second and third day he was a part of two panel discussions, one with other Thiel fellows and the other with Sabah Oney (VP of Business Development at Ariosa Diagnostics).
September 1, 2015 - Tuesday
Michael Otte is joining Freenome from California. With experience and expertise in software, product development, and translational research in immunology, he will contribute to the new product team.
We have some exciting news to share. Our President and CEO, Gabriel Otte has been selected as one of the Healthcare Innovator of the Year by the Business Journals for his groundbreaking work in cell-free DNA and cancer screening. He will be honored in Philadelphia along with fellow award winners Carl June and Scott Levin on October 22nd.
More information can be found here:
Congratulations to Gabriel and thank you to everyone at Freenome for their hard work!
Out of more than 1,300 entries, Freenome was selected by Verizon Wireless to be one of the recipients of the Verizon Powerful Answers Award in the Healthcare space. The non-dilutive cash prize will be used to fund the next stage of research and development to bring about the future of cancer diagnosis in the form of the "liquid biopsy."
The full story can be found here.